Clinical decision making for CTO PCI strategy

Session comprising selected EuroPCR 2026 clinical cases submissions

Moderators: K. Tigen, J. Davies

Summary

This session explores clinical decision-making in CTO PCI strategy through complex scenarios including multivessel CTO in ischemic cardiomyopathy, high-risk NSTEMI post-vein graft failure, and challenges in elderly patients. It emphasizes strategic planning and individualized approaches to optimize outcomes.

Presentations available when logged in:

  • Radiation's long shadow: multivessel CTO and ischemic cardiomyopathy in a young lymphoma survivor
  • High risk NSTEMI after vein graft failure: rethinking the target
  • Native CTO PCI vs. recurrent saphenous vein graft PCI in the elderly
  • Taking the last option on the CTO PCI